CHINA PHARMA HOLDINGS, INC. Diluted Shares Outstanding (Weighted Average)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Diluted Shares Outstanding (Weighted Average) of 40.52 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 40.52M shares, a 1156.05% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 25.60M shares, a 684.88% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 3.23M shares.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 3.26M shares.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2015 was 43.58M shares, a 0.00% change from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2014 was 43.58M shares.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2012 was 43.58M shares, a 0.23% increase from fiscal 2011.
- CHINA PHARMA HOLDINGS, INC. weighted average number of shares outstanding, diluted for fiscal 2011 was 43.48M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 40.52M shares 10-Q · filed 2026-08-14 | 34.09M shares 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | 25.60M shares 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | 3.23M shares 10-Q · filed 2026-08-14 | 3.26M shares 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | 3.26M shares 10-Q · filed 2026-05-15 | |||
| 2016-09-30 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 |
| 2016-06-30 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares derived: average of 3 quarters · filed 2016-08-11 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 |
| 2016-03-31 | 43.58M shares 10-Q · filed 2016-05-16 | 43.58M shares derived: average of 2 quarters · filed 2016-05-16 | 43.58M shares derived: average of 3 quarters · filed 2016-11-14 | 43.58M shares derived: average of 4 quarters · filed 2016-11-14 |
| 2015-12-31 | 43.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares derived: average of 3 quarters · filed 2016-11-14 | 43.58M shares 10-K · filed 2016-03-30 |
| 2015-09-30 | 43.58M shares 10-Q · filed 2016-11-14 | 43.58M shares derived: average of 2 quarters · filed 2016-11-14 | 43.58M shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 43.58M shares 10-Q · filed 2016-08-11 | 43.58M shares 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | 43.58M shares 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | 43.58M shares 10-K · filed 2016-03-30 | |||
| 2013-06-30 | 43.58M shares 10-Q · filed 2013-08-14 | 43.58M shares 10-Q · filed 2013-08-14 | 43.60M shares derived: average of 3 quarters · filed 2013-08-14 | 43.59M shares derived: average of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | 43.58M shares 10-Q · filed 2013-05-14 | 43.61M shares derived: average of 2 quarters · filed 2013-05-14 | 43.59M shares derived: average of 3 quarters · filed 2013-05-14 | 43.59M shares derived: average of 4 quarters · filed 2013-08-14 |
| 2012-12-31 | 43.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | 43.60M shares derived: average of 2 quarters · filed 2013-03-14 | 43.59M shares derived: average of 3 quarters · filed 2013-08-14 | 43.58M shares 10-K · filed 2013-03-14 |
| 2012-09-30 | 43.56M shares 10-Q · filed 2012-11-14 | 43.57M shares derived: average of 2 quarters · filed 2013-08-14 | 43.56M shares 10-Q · filed 2012-11-14 | 43.55M shares derived: average of 4 quarters · filed 2013-08-14 |
| 2012-06-30 | 43.57M shares 10-Q · filed 2013-08-14 | 43.55M shares 10-Q · filed 2013-08-14 | 43.54M shares derived: average of 3 quarters · filed 2013-08-14 | 43.54M shares derived: average of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | 43.53M shares 10-Q · filed 2013-05-14 | 43.53M shares derived: average of 2 quarters · filed 2013-05-14 | 43.53M shares derived: average of 3 quarters · filed 2013-05-14 | |
| 2011-12-31 | 43.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | 43.53M shares derived: average of 2 quarters · filed 2013-03-14 | 43.48M shares 10-K · filed 2013-03-14 | |
| 2011-09-30 | 43.53M shares 10-Q · filed 2012-11-14 | 43.46M shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |